Bausch Health Companies | Ativo Circulante



Current Assets Alterar Data
Amgen USD 26.73B 195M 2025-06
ANI Pharmaceuticals USD 602.63M 66.34M 2025-06
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 6.51B 782M 2025-06
Biogen USD 7.97B 341.7M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Danaher USD 11B 1.47B 2025-06
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 49.85B 8.59B 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
Novo Nordisk 162.71B 11.69B 2025-06
Pacira USD 745.61M 14.35M 2025-06
Perrigo USD 2.62B 82M 2025-06
Prestige Brands USD 480.52M 32.19M 2025-06
Supernus Pharmaceuticals USD 738.87M 51.28M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06
Zoetis USD 5.92B 46M 2025-06


Bausch Health Companies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.